-
Committing to cell division may be clue to cancer cell growth
-
Fighting a rare central nervous system tumor with research and optimism
-
Antibody-linked drug shrinks various types of tumors in preclinical study
-
Clinical trial tests combination therapy for prostate cancer
-
Clinical trial tests drug combination in mesothelioma of the lung or abdomen
-
@theNCI is hosting a Facebook Live event on the @NIH gastrointestinal stromal tumor or GIST clinic. Experts Dr. Fer… https://t.co/vAnW4Kdd3w
-
What is cancer #immunotherapy? Nick Restifo @nrestifo @NCI_CCR_SB describes here... #CIM18 Learn more about Dr. Res… https://t.co/qW61uEvSgq
-
#PLOSONE: Four-dimensional, dynamic mosaicism is a hallmark of normal human skin that permits mapping of the ... https://t.co/5PaSfaIPwE
-
RT @theNCI: What is #immunotherapy for patients with cancer? This type of treatment strengthens the body's immune response agai… https://t.co/pAJ0Cg9isp
-
Results from pediatric #clinicaltrial support use of selumetinib for children with #NF1 https://t.co/zbsukjIJGi
-
Findings from #clinicaltrial suggest moxetumomab pasudotox may be effective treatment option for rare #leukemia https://t.co/F3bQ8UiHtT
-
RT @FredNatLab_PDO: Cryo-EM reveals interaction between major drug targets. Structure provides “blueprint” for drug development, answer… https://t.co/HQpGR1BzwT
